News
Gavin Herbert is winning converts to his latest venture, which is trying to solve Long Covid.The founder of Allergan is ...
The University of Michigan has sued pharmaceutical giant AstraZeneca, alleging the company is still using the university's intellectual property in FluMist two years after the licensing agreement ...
An unmet need exists for effective therapies to lower triglyceride levels in patients with residual cardiovascular risk despite optimal lipid-lowering therapies. The ESSENCE-TIMI 73b trial ...
The Chesapeake and Delaware are the main office buildings on the south campus and formally are on the market, said Michele L.
A monthly injection of olezarsen reduced triglyceride levels in adults with elevated cardiovascular risk. More than 80% of patients assigned olezarsen achieved a normal triglyceride level at 6 months.
A King's Award-winning inspection firm, which dates back to 1881, has been revealed as the top company for international sales in the Liverpool City Region, according to Insider's Global North 500 ...
DelveInsight's Asthma Market Insights report includes a comprehensive understanding of current treatment practices, asthma ...
DelveInsight's GLP-1 Agonists Market Size, Target Population, Competitive Landscape & Market Forecast report includes a ...
ASCO Guidelines provide recommendations with comprehensive review and analyses of the relevant literature for each recommendation, following the guideline development process as outlined in the ASCO ...
Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium Subcutaneous amivantamab-lazertinib demonstrated noninferior ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results